Managing Informed Participant Consent in Medical Research

Turn informed consent in research from a stated policy into a practice your organisation can evidence.

📍 Tripoli🗓️ 5 training days📚 4 modules🎓 Accredited certificate
5intensive training days
4scientific modules
8training sessions
32detailed points

Course Overview

Variation in informed consent in research between shifts and sites is where avoidable harm lives. In healthcare, a weakness in consent in research is eventually paid for by a patient. The course sets out a working method for this part of health and pharmaceutical services that participants can apply the week they return. Participants finish able to explain informed consent in research to a non-specialist audience without losing precision. The content is relevant to those who own this area of health and pharmaceutical services and to those who are held accountable for its results. Teams frequently over-invest in documenting consent in research and under-invest in testing it. Benchmarking exercises repeatedly place informed consent in research among the areas with the widest performance spread. Discussion is anchored to worked examples of consent in research rather than to abstract argument. Participants leave with a plan for the wider health and pharmaceutical services agenda sized to what their organisation can realistically absorb.

Expected Learning Outcomes

01

Apply regulatory and licensing requirements governing informed consent in research.

02

Establish escalation routes for consent in research that work outside normal hours.

03

Document decisions about informed consent in research in a form that remains useful after the people change.

04

Review contracts and agreements for the obligations they create around consent in research.

05

Design medication and treatment safety controls within informed consent in research.

06

Manage the supply chain and cold chain supporting consent in research.

07

Establish incident and near-miss reporting on informed consent in research that staff trust.

Who Should Attend

01

Infection prevention and control practitioners covering informed consent in research.

02

Medical directors overseeing clinical governance of consent in research.

03

Pharmacists and pharmacy managers involved in informed consent in research.

04

Staff seconded into improvement work on consent in research.

05

Regulatory affairs specialists handling informed consent in research.

06

Experienced practitioners formalising an approach to consent in research that has grown up informally.

Course Modules

01

Informed consent in research: cost, efficiency and sustainability of the service

2 sessions · 8 points

Session 1Closing out informed consent in research and capturing what was learned

  • Build the competence framework that supports informed consent in research.
  • Arrange the handover of consent in research so capability survives staff changes.
  • Establish the boundary of informed consent in research and record what sits outside it.
  • Check that records of consent in research answer the questions likely to be asked.

Session 2Reading the current state of consent in research honestly

  • Map the clinical workflow for informed consent in research as it is actually performed.
  • Confirm that reporting on consent in research reaches the people who can act.
  • Match staffing levels on informed consent in research to measured demand across the week.
  • Assign responsibility for keeping documentation of consent in research current.
02

Consent in research: regulation, licensing and accreditation evidence

2 sessions · 8 points

Session 1Auditing consent in research at the bedside, not in the binder

  • Plan continuity of informed consent in research during surge and outbreak conditions.
  • Confirm the incident reporting route for consent in research is quick and non-punitive.
  • Agree the smallest change to informed consent in research that would be visibly useful.
  • Verify cold chain and storage conditions for materials used in consent in research.

Session 2Comparing consent in research with recognised practice

  • Confirm competence and continuing development for staff delivering informed consent in research.
  • Rehearse the briefing on consent in research that would follow an incident.
  • Map the handovers in informed consent in research between functions and secure them.
  • Assemble the accreditation evidence pack for consent in research.
03

Consent in research: quality indicators and patient outcome

2 sessions · 8 points

Session 1Consent, confidentiality and ethics in consent in research

  • Close the loop: confirm changes to informed consent in research improved the indicator they targeted.
  • Plan the sequence in which improvements to consent in research will be introduced.
  • Prepare the summary of informed consent in research that senior management will read.
  • Select quality indicators for consent in research that measure outcome rather than activity.

Session 2Matching staffing on informed consent in research to real demand

  • Define escalation criteria for deterioration detected through informed consent in research.
  • Set the review interval for consent in research and who attends.
  • Anticipate the objections informed consent in research will raise and prepare the answers.
  • Confirm licensing and regulatory requirements applying to consent in research are met.
04

Consent in research: supply, cold chain and availability

2 sessions · 8 points

Session 1Making incident reporting on consent in research safe for staff

  • Record what was learned when informed consent in research did not go as planned.
  • Measure patient experience of consent in research and feed it back to the team.
  • Cost informed consent in research per episode and identify avoidable waste.
  • Reduce unwarranted variation in consent in research between shifts and sites.

Session 2Designing consent in research so it helps rather than obstructs care

  • Identify where judgement in informed consent in research is legitimate and where it is not.
  • Check that consent processes within consent in research are genuinely informed.
  • Distinguish symptoms from causes when informed consent in research underperforms.
  • Apply structured root cause analysis to the last adverse event involving consent in research.

Choose the package that suits you

Silver Package

At least 3 people

USD1,250
  • Workshop or Program Participation
  • Airport Transfers
  • Customized Badge
  • Expert Mentorship (Private Sessions)
  • Supervision & Secretarial Services
  • Accredited Certificate of Participation
  • Complete Training Kit
  • Coffee Break
  • Closing Ceremony

Gold Package

At least 3 people

USD1,850
  • 5-night stay in a 5-star hotel
  • Workshop or Program Participation
  • Airport Transfers
  • Customized Badge
  • Expert Mentorship (Private Sessions)
  • Supervision & Secretarial Services
  • Accredited Certificate of Participation
  • Complete Training Kit
  • Coffee Break
  • Closing Ceremony

Complete your registration

We will contact you within one business day to confirm.